Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Many people also find it helps them achieve deeper, more restorative sleep and contributes to healthier skin
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry Rhea-AI Summary Lexaria (NASDAQ:LEXX) outlines its strategy to develop oral GLP-1 capsule and tablet alternatives using its patented DehydraTECH platform, citing intellectual property established in 20242025 and early-stage commercial discussions with several multinational pharmaceutical companies
Employers seek solutions While these drugs represent a small fraction of prescriptions, their financial impact is outsized
Commercialization vs
Giardia duodenalis GlSir2.2, homolog of SIRT1, is a nuclear-located and [PMID: 27423969] Laboratory literature summary: Giardia duodenalis GlSir2.2, homolog of SIRT1, is a nuclear-located and NAD(+)-dependent deacethylase
IGF-1 LR3 (Long R3 IGF-1) is a synthetic analog constructed by adding a 13-amino-acid N-terminal extension and substituting arginine for glutamic acid at position 3 of the mature IGF-1 sequence
US$ 27.51
US$ 21.75
US$ 27.40
US$ 28.29
US$ 26.04
US$ 25.70
